Blue Cross and Blue Shield of South Carolina et al v. Gilead Sciences, Inc. et al
Blue Cross and Blue Shield of South Carolina and BlueChoice HealthPlan of South Carolina, Inc. |
Gilead Sciences, Inc., Gilead Holdings, LLC, Gilead Sciences, LLC, Gilead Sciences Ireland UC, Bristol-Myers Squibb Company, E.R. SQUIBB & SONS, L.L.C., Janssen Products, L.P. and Janssen R&D Ireland |
3:2021cv09645 |
December 14, 2021 |
U.S. District Court for the Northern District of California |
Edward M Chen |
Anti-Trust |
15 U.S.C. § 1 |
Plaintiff |
Docket Report
This docket was last retrieved on December 14, 2021. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 2 Corporate Disclosure Statement by Blue Cross and Blue Shield of South Carolina, BlueChoice HealthPlan of South Carolina, Inc. identifying Corporate Parent Blue Cross and Blue Shield of South Carolina for BlueChoice HealthPlan of South Carolina, Inc.. (Sasse, Daniel) (Filed on 12/14/2021) |
Filing 1 COMPLAINT against All Defendants ( Filing fee $ 402, receipt number ACANDC-16720649.). Filed byBlueChoice HealthPlan of South Carolina, Inc., Blue Cross and Blue Shield of South Carolina. (Attachments: #1 Civil Cover Sheet)(Sasse, Daniel) (Filed on 12/14/2021) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the California Northern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.